BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
FXYD4
,
T cell receptor signaling pathway
,
Ischemia
,
Breast
,
Lovastatin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
chelators
Summary
General Info
Curated Studies
Most Correlated Studies
Myoblast C2C12 cells overexpressing GFP-tagged PGC-1a and treated with chelator deferoxamine
Colorectal cancer SW 480 cells treated with iron chelators deferasirox or desferrioxamine
Liver, breast and endometrial cell lines exposed to 34 toxicological compounds
Cerebrocortical cells treated with blood-brain barrier penetrant clinic-tested drugs
Effect of hypoxia (1% O2) and hypoxia mimics (cobalt chloride, deferoxamine and nickel chloride)
Explore Curated Studies Results
Literature
Most Relevant Literature
Chelators as Antineuroblastomas Agents.
EHDTA: a green approach to efficient Ln3+-chelators.
Chelating agents for metal intoxication.
Coordination Chemistry of Sulfur-Containing Bifunctional Chelators: Toward in Vivo Stabilization of …
Emerging Roles of the Iron Chelators in Inflammation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Trial to Assess Chelation Therapy 2
Trial to Assess Chelation Therapy (TACT)
Chronic Lymphocytic Leukemia Responds to Dermal Chelation
Role of Vitamin C to Augment Iron Chelation With DFP or DFX
Penicillamine Chelation for Children With Lead Poisoning
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ